CPT2 and hepatocellular carcinoma: Knockdown of CPT2 can promote adipogenesis in cancer cells through upregulation of stearoyl coenzyme A desaturase 1 (SCD1), which significantly enhances hepatocellular carcinoma tumorigenicity, metastatic potential, and cisplatin resistance [125].